AI Article Synopsis

  • The paper introduces a method to evaluate whether drug treatments are appropriate by combining economic analysis, pharmacoepidemiology, and evidence-based information.
  • It creates an index that compares expected health gains (EHG) to national drug spending (EXPEND) and actual health gains in patients (RHG).
  • The main goal is to propose a ranking system for effectively distributing drug budgets within national health systems.

Article Abstract

This paper presents a method to assess drug treatment appropriateness, based on an original combination of economic analysis, pharmacoepidemiological techniques and evidence-based information. This method generates an index of clinical-economic appropriateness for the treatment under examination, by comparing the theoretically expected health gain (EHG) to the yearly national expenditure (EXPEND) on that drug and the amount of health that is thought to be gained in the 'real' patients (RHG). This paper reviews all the analyses conducted so far using this method, and discusses their main results. The primary aim of this article is to suggest a ranking approach for allocating the drug budgets of national health systems.

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.5.11.2381DOI Listing

Publication Analysis

Top Keywords

clinical-economic appropriateness
8
drug
4
appropriateness drug
4
drug treatments
4
treatments designing
4
method
4
designing method
4
method combines
4
combines evidence-based
4
evidence-based cost
4

Similar Publications

Negative pressure wound therapy is used often in the management of surgical incisions, chronic wounds and subacute lesions, and there are numerous publications discussing its clinical application and outcomes. However, whilst clinical use and associated literature have expanded since these systems became commercially available in the 90s, important research and discussion around the mode of action have waned, leading to a deficit in the understanding of how this important therapy influences healing. Further, much research and many publications are predominantly reflective, discussing early theorem, some of which have been proven incorrect, or at least not fully resolved leading to misunderstandings as to how the therapy works, thus potentially denying the clinician the opportunity to optimise use towards improved clinical and economic outcomes.

View Article and Find Full Text PDF

Background: Patients with kidney failure treated with maintenance haemodialysis (HD) require appropriate small molecule clearance. Historically, a component of measuring 'dialysis adequacy' has been quantified using urea kinetic modelling that is dependent on the HD prescription. However, the impact of dialysate flow rate on urea clearance remains poorly described and its influence on other patient-important outcomes of adequacy is uncertain.

View Article and Find Full Text PDF

Multi-Criteria Decision Analysis (MCDA) has gained increasing attention in supporting drug risk-benefit assessment, pricing and reimbursement, as well as optimization of clinical interventions. The objective of this study was to systematically collect and categorize evaluation criteria and techniques of weighting and scoring of MCDA for drug value assessment. A systematic review of the literature was conducted across seven databases to identify articles utilizing the MCDA frameworks for the evaluation of drug value.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on RSV, a common virus causing severe respiratory infections in infants, particularly in those under two months old, and evaluates its impact on hospitalizations at Policlinico Foggia Hospital in Italy from 2011 to 2023.
  • - Data from 1,005 RSV cases reveals that most hospitalizations occur during winter months, with a significant majority of affected patients being under one year old, and highlights that factors such as younger age, longer hospital stays, and prematurity increase disease severity.
  • - The financial burden of RSV hospitalizations averages around 3,036 euros annually, with costs being notably higher for the youngest patients, indicating the potential benefits of new immunization strategies, including the use of monoclon
View Article and Find Full Text PDF

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors.

J Clin Med

April 2023

Internal Medicine Unit, E.O. Ospedali Galliera, Mura Delle Cappuccine, 14, 16128 Genoa, Italy.

Proton pump inhibitors (PPIs) are among the most controversially prescribed drugs in polypharmacy. This observational prospective study assessed the PPI prescriptive trend during hospitalization before and after implementation of a prescribing/deprescribing algorithm in a real-life hospital setting and the related clinical-economic benefit at discharge. PPI prescriptive trends were compared between three quarters of 2019 (9 months) and the same period of 2018 by a chi-square test with a Yate's correction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!